DUBLIN, Nov 11, 2016 /PRNewswire/ -- Research and Markets has announced the addition of the "US Market Report for Middle Ear Implants 2017 - MedCore" report to their offering.
This market experienced moderate growth beginning in 2010, as middle ear implants received approval to treat mixed and conductive hearing loss and provide another treatment option for patients with damaged or malformed inner ears. Nevertheless, there is virtually no reimbursement for these products. At such a high cost, their growth is extremely limited to patients who can afford them. Success in this market will depend upon whether companies can get reimbursement for these products. Furthermore, market growth resulting from any future approvals is expected to be small, as bone-anchored hearing aids already treat mixed and conductive hearing loss and are much less expensive. Any share in that particular market must be won by quality and patient satisfaction, which is expected to be high with middle ear treatment. MEIs can further be broken up into fully-implantable and semi-implantable devices. Semi-implantable devices consist of three components: a magnetic part implanted onto the ossicles of the ear, a receiver, and a processor. The processor receives and communicates the sound vibrations by transforming the vibrations into electrical signals. An electromagnetic field is created that causes vibration of the bones of the middle ear in a manner that is similar to normal hearing. There are currently two FDA approved semi-implantable devices: The Vibrant Soundbridge (Med-El) and the Maxum implant (Ototronix). Key Topics Covered: 1. Executive SummaryU.S. Hearing Aids And Audiology Device Market Overview Competitive Analysis Market Trends Market Developments Markets Included Key Report Updates Version History Research Methodology 2. Middle Ear Implant Market 2.1 Introduction 2.2 Market Analysis And Forecast 2.3 Drivers And Limiters 2.3.1 Market Drivers 2.3.2 Market Limiters 2.4 Competitive Market Share Analysis